Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Intangibles (2016 - 2025)

Historic Intangibles for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $2.3 billion.

  • Prestige Consumer Healthcare's Intangibles fell 39.44% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year decrease of 39.44%. This contributed to the annual value of $2.3 billion for FY2025, which is 108.74% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Intangibles stood at $2.3 billion for Q4 2025, which was down 39.44% from $2.3 billion recorded in Q3 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Intangibles peaked at $2.7 billion during Q4 2021, and registered a low of $2.3 billion during Q3 2025.
  • Moreover, its 5-year median value for Intangibles was $2.3 billion (2023), whereas its average is $2.4 billion.
  • In the last 5 years, Prestige Consumer Healthcare's Intangibles surged by 894.1% in 2021 and then crashed by 1315.5% in 2023.
  • Prestige Consumer Healthcare's Intangibles (Quarter) stood at $2.7 billion in 2021, then decreased by 1.23% to $2.7 billion in 2022, then dropped by 12.8% to $2.3 billion in 2023, then dropped by 0.77% to $2.3 billion in 2024, then fell by 0.39% to $2.3 billion in 2025.
  • Its Intangibles was $2.3 billion in Q4 2025, compared to $2.3 billion in Q3 2025 and $2.3 billion in Q2 2025.